SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001113148-22-000022
Filing Date
2022-11-14
Accepted
2022-11-14 06:48:01
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q infi-20220930.htm   iXBRL 10-Q 938730
2 EX-31.1 ex-311q32022.htm EX-31.1 9070
3 EX-31.2 ex-312q32022.htm EX-31.2 9492
4 EX-32.1 ex-321q32022.htm EX-32.1 4374
5 EX-32.2 ex-322q32022.htm EX-32.2 4405
  Complete submission text file 0001113148-22-000022.txt   4215190

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20220930.xsd EX-101.SCH 40150
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT infi-20220930_cal.xml EX-101.CAL 43986
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT infi-20220930_def.xml EX-101.DEF 132077
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20220930_lab.xml EX-101.LAB 429184
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20220930_pre.xml EX-101.PRE 247101
52 EXTRACTED XBRL INSTANCE DOCUMENT infi-20220930_htm.xml XML 579409
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 221379961
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences